ZIH

Zih Yuan Tang Biotechnology is a Taiwan-based private biotech company developing small-molecule therapeutics derived from traditional Chinese medicinal herbs. The company focuses on identifying active bio-molecules from herbal formulations and advancing them using modern pharmacology and drug development methods. Its lead disclosed program is an oral small molecule for diabetic retinopathy, especially non-proliferative diabetic retinopathy, and the company has also described work in diabetes, diabetic wound healing, and cancer. Zih Yuan Tang presents itself as a discovery and early development company seeking partners and investors to help advance its assets toward regulatory development and commercialization.